[SCHEDULE 13G/A] Neuronetics, Inc. Amended Passive Investment Disclosure
Neuronetics, Inc. filing amends beneficial ownership disclosure for Jorey Chernett.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Neuronetics, Inc. filing amends beneficial ownership disclosure for Jorey Chernett. As of the close of business on March 17, 2026, the Reporting Person beneficially owned 7,516,404 shares of Common Stock, representing 10.85% of the class based on 69,276,593 Shares outstanding as of March 10, 2026.
The amendment updates the Schedule 13G/A ownership figures and reports sole voting and dispositive power over the disclosed shares. The statement is signed and dated 03/18/2026.
Insights
Disclosure clarifies a >10% stake by an individual investor.
The filing documents that Jorey Chernett beneficially owns 7,516,404 shares, equal to 10.85% of outstanding common stock using the issuer's stated outstanding share count of 69,276,593 as of March 10, 2026. This meets the Schedule 13G/A threshold for beneficial owner reporting.
The primary dependency is the issuer's outstanding share count cited from the Form S-3; any future updates to outstanding shares would change the percent calculation. Subsequent filings could adjust ownership percentages if shares are acquired or disposed.
AI-generated analysis. How Rhea-AI works. Not financial advice.